• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气流阻塞作为类风湿关节炎不良预后的一个标志物。

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis.

作者信息

Guiot Julien, Henket Monique, Ernst Marie, Seidel Laurence, Winandy Marie, Denis Anna, Frix Anne-Noëlle, Gester Fanny, Thys Marie, Giltay Laurie, Garah Omaima, Njock Makon-Sébastien, Canivet Perrine, Meunier Paul, Corhay Jean-Louis, Regnier Céline, Malaise Olivier, Malaise Michel, Louis Renaud

机构信息

Department of Respiratory Medicine, CHU Liège, Liège, Belgium.

Biostatistics and Research Method Center (B-STAT), CHU Liège, Liège, Belgium.

出版信息

Front Med (Lausanne). 2023 Mar 9;10:1063012. doi: 10.3389/fmed.2023.1063012. eCollection 2023.

DOI:10.3389/fmed.2023.1063012
PMID:36968825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10033600/
Abstract

OBJECTIVES

In our study, we explored the specific subgroup of patients with rheumatoid arthritis (RA) suffering from obstructive lung disease (OLD) and its impact on morbi-mortality.

METHODS

Our retrospective study included 309 patients suffering from RA with either obstructive (O-RA) or non-obstructive patterns (non-O-RA). OLD was defined based on the Tiffeneau index at the first available pulmonary functional test (PFT). Survival was then calculated and represented by a Kaplan-Meier curve. The comparison between the populations considered was performed by the Log-Rank test.

RESULTS

Out of the 309 RA patients, 102 (33%) had airway obstruction. The overall survival time was significantly lower in the O-RA group than in the non-O-RA group ( = 207) ( < 0.001). The median survival time was 11.75 years in the O-RA group and higher than 16 years in the non-O-RA group. Multivariate analysis identified OLD as an independent risk factor for mortality (HR 2.20; 95% CI 1.21-4.00,  < 0.01).

CONCLUSION

Airway obstruction can be an independent risk factor of mortality in RA and should be considered as an early marker of poor prognosis. Further prospective longitudinal studies are required in order to determine the best clinical management for O-RA patients.

摘要

目的

在我们的研究中,我们探索了患有阻塞性肺病(OLD)的类风湿关节炎(RA)患者的特定亚组及其对疾病死亡率的影响。

方法

我们的回顾性研究纳入了309例患有阻塞性(O-RA)或非阻塞性模式(非O-RA)类风湿关节炎的患者。OLD根据首次可用肺功能测试(PFT)时的蒂芬诺指数定义。然后计算生存率并用Kaplan-Meier曲线表示。所考虑人群之间的比较通过对数秩检验进行。

结果

在309例类风湿关节炎患者中,102例(33%)存在气道阻塞。O-RA组的总生存时间显著低于非O-RA组(=207)(<0.001)。O-RA组的中位生存时间为11.75年,非O-RA组高于16年。多变量分析确定OLD是死亡率的独立危险因素(HR 2.20;95%CI 1.21-4.00,<0.01)。

结论

气道阻塞可能是类风湿关节炎患者死亡的独立危险因素,应被视为预后不良的早期标志物。需要进一步的前瞻性纵向研究以确定O-RA患者的最佳临床管理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa0b/10033600/0940f17ed99d/fmed-10-1063012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa0b/10033600/0940f17ed99d/fmed-10-1063012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa0b/10033600/0940f17ed99d/fmed-10-1063012-g001.jpg

相似文献

1
Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis.气流阻塞作为类风湿关节炎不良预后的一个标志物。
Front Med (Lausanne). 2023 Mar 9;10:1063012. doi: 10.3389/fmed.2023.1063012. eCollection 2023.
2
Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.类风湿关节炎登记研究中类风湿关节炎相关自身抗体与肺功能检查异常的相关性。
Clin Rheumatol. 2019 Dec;38(12):3401-3412. doi: 10.1007/s10067-019-04733-9. Epub 2019 Aug 13.
3
Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).纤维化性间质性肺炎可预测类风湿关节炎相关间质性肺病(RA-ILD)患者的生存情况。
Respir Med. 2013 Aug;107(8):1247-52. doi: 10.1016/j.rmed.2013.05.002. Epub 2013 Jun 19.
4
Patterns of interstitial lung disease and mortality in rheumatoid arthritis.类风湿关节炎中间质性肺疾病的模式与死亡率
Rheumatology (Oxford). 2017 Mar 1;56(3):344-350. doi: 10.1093/rheumatology/kew391.
5
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.类风湿关节炎相关间质性肺疾病进展的危险因素:临床特征、生物标志物和治疗选择。
Semin Arthritis Rheum. 2022 Aug;55:152004. doi: 10.1016/j.semarthrit.2022.152004. Epub 2022 Apr 11.
6
Predictors of mortality in rheumatoid arthritis-associated lung disease: A retrospective study on ten years.类风湿关节炎相关肺部疾病死亡率的预测因素:一项十年回顾性研究。
Joint Bone Spine. 2021 May;88(3):105133. doi: 10.1016/j.jbspin.2021.105133. Epub 2021 Jan 20.
7
A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.类风湿关节炎相关间质性肺疾病患者的临床特征和治疗管理的预测意义的回顾性研究。
Clin Rheumatol. 2020 May;39(5):1457-1470. doi: 10.1007/s10067-019-04846-1. Epub 2019 Dec 19.
8
Assessment of interstitial lung disease among black rheumatoid arthritis patients.评估黑人类风湿关节炎患者的间质性肺病。
Clin Rheumatol. 2019 Dec;38(12):3413-3424. doi: 10.1007/s10067-019-04760-6. Epub 2019 Aug 30.
9
Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis.类风湿关节炎相关间质性肺疾病急性加重的临床特征:与特发性肺纤维化的比较。
Respir Med. 2022 Aug-Sep;200:106898. doi: 10.1016/j.rmed.2022.106898. Epub 2022 Jun 4.
10
Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.与类风湿关节炎间质性肺病发生和预后不良相关的临床特征。
Korean J Intern Med. 2019 Mar;34(2):434-441. doi: 10.3904/kjim.2016.349. Epub 2017 Mar 28.

本文引用的文献

1
Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study.类风湿关节炎中的进行性纤维化间质性肺疾病:一项回顾性研究。
Front Med (Lausanne). 2022 Nov 30;9:1024298. doi: 10.3389/fmed.2022.1024298. eCollection 2022.
2
Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?合并阻塞性气流受限与间质性肺疾病(O-ILD):不良表型?
Respir Res. 2022 Apr 11;23(1):89. doi: 10.1186/s12931-022-02006-9.
3
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.
类风湿关节炎相关间质性肺疾病:发病机制与治疗的临床表现和最新认识。
Eur Respir Rev. 2021 Jun 23;30(160). doi: 10.1183/16000617.0011-2021. Print 2021 Jun 30.
4
Obstructive lung diseases and risk of rheumatoid arthritis.阻塞性肺疾病与类风湿关节炎风险。
Expert Rev Clin Immunol. 2020 Jan;16(1):37-50. doi: 10.1080/1744666X.2019.1698293. Epub 2020 Jan 6.
5
Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.类风湿关节炎相关慢性阻塞性肺疾病:系统评价和荟萃分析。
Respir Res. 2019 Jul 9;20(1):144. doi: 10.1186/s12931-019-1123-x.
6
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.类风湿关节炎肺部受累的临床、流行病学和组织病理学特征。
Biomed Res Int. 2017;2017:7915340. doi: 10.1155/2017/7915340. Epub 2017 Nov 7.
7
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
8
Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.类风湿关节炎相关自身抗体与亚临床间质性肺疾病:动脉粥样硬化多民族研究
Thorax. 2016 Dec;71(12):1082-1090. doi: 10.1136/thoraxjnl-2016-208932. Epub 2016 Sep 8.
9
Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study.托珠单抗、利妥昔单抗、阿巴西普及抗肿瘤坏死因子α制剂使用者间质性肺疾病的发病率和并发症:一项回顾性队列研究
Arthritis Res Ther. 2015 Nov 11;17:319. doi: 10.1186/s13075-015-0835-7.
10
Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.慢性阻塞性肺疾病中的炎症及其在心血管疾病和肺癌中的作用。
Clin Transl Med. 2015 Dec;4(1):68. doi: 10.1186/s40169-015-0068-z. Epub 2015 Jul 29.